Table 3.
Admission (/Lyphocytes, %) |
Discharge |
3 months |
||||||
---|---|---|---|---|---|---|---|---|
NIHSS ≥ 5 |
mRS ≥ 3 |
NIHSS ≥ 2 |
mRS ≥ 2 |
|||||
OR (95% CI) | P Value | OR (95% CI) | P Value | OR (95% CI) | P Value | OR (95% CI) | P Value | |
Bregs | 1.19 (0.98–1.46) | 0.085 | 1.21 (1.00–1.45) | 0.047 | 1.14 (0.87–1.50) | 0.354 | 0.97 (0.82–1.14) | 0.698 |
CD4+ Tregs | 0.47 (0.26–0.85) | 0.012 | 0.44 (0.25–0.75) | 0.003 | 0.74 (0.33–1.65) | 0.459 | 1.59 (1.01–2.50) | 0.043 |
CD8+ Tregs | 0.75 (0.48–1.15) | 0.180 | 1.07 (0.75–1.51) | 0.720 | 0.91 (0.51–1.63) | 0.740 | 1.20 (0.87–1.64) | 0.268 |
DNTs | 1.02 (0.85–1.23) | 0.808 | 0.97 (0.81–1.15) | 0.708 | 1.03 (0.80–1.34) | 0.803 | 1.04 (0.90–1.21) | 0.575 |
Data were analyzed using binary logistic regression. OR: odds rate; CI: confidence interval; NIHSS: National Institutes of Health Stroke Scale; mRS: modified Rankin Scale.